e-learning
resources
Stockholm 2002
Sunday 15.09.2002
Thoracic oncology: clinical management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adenovirus-mediated interferon-beta gene therapy inhibits tumor growth and inhibits metastatic lung tumors in mice
R. Wiewrodt, M. Odaka, P. DeLong, T. Tanaka, V. Kapoor, K. Amin, L. R. Kaiser, S. M. Albelda (Philadelphia, United States Of America; Mainz, Germany)
Source:
Annual Congress 2002 - Thoracic oncology: clinical management
Session:
Thoracic oncology: clinical management
Session type:
Poster Discussion
Number:
1186
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Wiewrodt, M. Odaka, P. DeLong, T. Tanaka, V. Kapoor, K. Amin, L. R. Kaiser, S. M. Albelda (Philadelphia, United States Of America; Mainz, Germany). Adenovirus-mediated interferon-beta gene therapy inhibits tumor growth and inhibits metastatic lung tumors in mice. Eur Respir J 2002; 20: Suppl. 38, 1186
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Inhibition of tumor growth and metastatic lung tumors in mice by adenovirus-mediated interferon-β gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 199s
Year: 2003
Adenovirus-mediated interferon-β gene therapy combined with radiotherapy synergistically inhibits lung tumor growth in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 79s
Year: 2004
Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis
Source: Eur Respir J 2002; 20: 703-709
Year: 2002
Interleukin-17 enhances the net angiogenic potential and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis
Source: Eur Respir J 2004; 24: Suppl. 48, 79s
Year: 2004
Splenectomy inhibits tumor development and metastases in murine lung cancer models
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012
Tissue inhibitor of metalloproteinase 3 inhibits growth of lung cancer tumours in nude mice
Source: Eur Respir J 2004; 24: Suppl. 48, 704s
Year: 2004
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumours and suppression of tumour growth
in vivo
by retrovirus-mediated gene transfer
Source: Annual Congress 2002 - Thoracic oncology: biology
Year: 2002
Erradication of intraperitoneal and distant tumour by adenovirus-mediated interferon-beta gene therapy due to induction of systemic immunity
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001
Intratumoral injection of plasmid-encoded flagellin inhibits growth of NSCLC-cells in murine lung cancer model
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Is caveolin-1 lost as a tumor suppressor gene in lung carcinoma?
Source: Annual Congress 2004 - Lung development and cancer
Year: 2004
Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Adenovirus-mediated AP-2α down-regulates MnSOD expression in lung cancer A549 cells and its molecular mechanism
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
Downregulation of expression growth factor receptor induced by vector-based siRNA and its effect on radiosensitivity of pulmonary adenocarcinoma cell line
Source: Eur Respir J 2006; 28: Suppl. 50, 810s
Year: 2006
Overexpression of LincR-PICALM promotes lung cancer proliferation and metastasis by miR-199a-3p suppression and cis- regulation
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019
Bevacizumab (Avastin®) aerosol therapy (AT) inhibits primary and metastatic tumor growth in a murine model with human non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
IGF1R facilitates implantation and progression of lung metastasis acting in the tumor microenvironment
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Effects of chemotherapeutic drugs and TRAIL (tumor necrosis factor-related apoptosis inducing ligand) on the non-small lung cancer cells
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Inhibition of insulin-like growth factor type I (IGF-I) gene in A549 human lung cancer cell line enhances cell apoptosis and causes phenotype changes relevant to increased tumor susceptibility to immune system
Source: Eur Respir J 2007; 30: Suppl. 51, 715s
Year: 2007
Effects of ASCL1 expression on tumorigenesis and immune cell infiltration in a syngenic mouse model of lung adenocarcinoma
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept